NCAM1 and neuroblastoma: Prior exposure of NKs to neuroblastoma cells increased the secretion of exosomes expressing NK receptors CD56, NKG2D, and KIR2DL2, and displayed greater cytotoxicity against neuroblastoma tumors relative to exosomes from naïve NK cells [81].